$CADX Cadence Pharmaceuticals (CADX) Overall Average: 56% Buy.

Centrus Energy Corp. Announces Q3 2024 Results Centrus Energy Corp. (NYSE American: LEU) has released its third quarter results for 2024, showcasing both challenges and significant developments for the company. Despite a net loss, the company recorded $57.7 million in revenue, which marks a notable increase from the previous year. This report highlights key financial...

Neuberger Berman Real Estate Fund Announces a New Rights Offering Neuberger Berman Real Estate Securities Income Fund Inc. (NYSE American: NRO) has innovative news for its common stockholders. The Fund has revealed the issuance of transferable rights to allow current stockholders the opportunity to subscribe for additional shares of Common Stock at advantageous terms....

ERES Announces January 2025 Cash Distribution European Residential Real Estate Investment Trust (TSX: ERE.UN, “ERES”) has made an important announcement regarding its monthly cash distribution for January 2025. This update clarifies earlier statements and provides shareholders with essential information regarding their investments. Details of the January 2025...

Guidant: A Revolutionary Shift in Cemetery Property Sales Fortitude Research and Marketing has officially launched Guidant, an innovative technology company that is breaking new ground in the digital commerce landscape for cemeteries and funeral homes. This unique platform has enabled families to purchase cemetery property and related services directly online—something...

Exciting Developments from Angel Yeast's Cup Finals Event Engaging the World Through Fermented Flour-Based Foods The Finals of the 8th Angel Yeast Cup Chinese Fermented Dim Sum Contest and the 12th Fermented Flour-Based Food Industry Development Conference recently concluded in a region acclaimed as the home of traditional Chinese staple foods. Angel Yeast Co., Ltd....